-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MUXGSxlf7g1GHjy8/7yAQ07DQyUpKMOt/OHXDXMBfwiIpw9Kce7a3exi4k3oVwe6 5mzAWjLd3FSTeUoNHyQFYQ== 0001104659-08-058025.txt : 20080910 0001104659-08-058025.hdr.sgml : 20080910 20080910170128 ACCESSION NUMBER: 0001104659-08-058025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080908 FILED AS OF DATE: 20080910 DATE AS OF CHANGE: 20080910 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szela Mary T CENTRAL INDEX KEY: 0001410289 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 081065701 BUSINESS ADDRESS: BUSINESS PHONE: (847) 937-6100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-6400 4 1 a4.xml 4 X0303 4 2008-09-08 0 0000001800 ABBOTT LABORATORIES ABT 0001410289 Szela Mary T 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Senior Vice President Common shares without par value 2008-09-08 4 M 0 2474 45.4488 A 98687 D Common shares without par value 2008-09-08 4 F 0 2036 57.01 D 96651 D Common shares without par value 8016 I Profit Sharing Trust Option (right to buy) 45.4488 2008-09-08 4 M 0 2474 0 D 2004-02-09 2011-02-08 Common Shares 2474 3445 D Option (right to buy) 57.01 2008-09-08 4 A 0 2036 0 A 2009-03-09 2011-02-08 Common Shares 2036 2036 D Balance in the Abbott Laboratories Stock Retirement Trust as of September 8, 2008. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on September 8, 2008. John A. Berry, by power of attorney for Mary T. Szela 2008-09-10 -----END PRIVACY-ENHANCED MESSAGE-----